DiEthylStilbestrol Resources: DES Effects on The Genital Tract

NCBI advances science & health by providing access to biological information

DES Effects on The Genital Tract

image of PubMed logo
NCBI PubMed DiEthylStilbestrol Resources: DES Effects on The Genital Tract.
More DES DiEthylStilbestrol Resources

DiEthylStilbestrol Resources: Epigenetics and Transgenerational Effects

NCBI advances science & health by providing access to biological information

Epigenetics

image of PubMed logo
NCBI PubMed DiEthylStilbestrol Resources: Epigenetics and Transgenerational Effects.

DES Transgenerational Effects

More DES DiEthylStilbestrol Resources

DiEthylStilbestrol Resources: Gender Identity and Psychological Health

NCBI advances science & health by providing access to biological information

Gender Identity

image of PubMed logo
NCBI PubMed DiEthylStilbestrol Resources: Gender Identity and Psychological Health.

Psychological Health

More DES DiEthylStilbestrol Resources

DiEthylStilbestrol Resources: DES Lawsuits

NCBI advances science & health by providing access to biological information

DES Lawsuits

Law Papers and Theories (in Reference to DES Cases)

image of PubMed logo
NCBI PubMed DiEthylStilbestrol Resources: Lawsuits and Various Studies.

DES Cases

For different topics (than law-related), go first to Diethylstilbestrol DES Studies.

More DES DiEthylStilbestrol Resources

DiEthylStilbestrol Resources: Fertility and Pregnancy

NCBI advances science & health by providing access to biological information

DES and Fertility

DES and Pregnancy

More DES DiEthylStilbestrol Resources

DiEthylStilbestrol Resources: Gestational DES-Exposure and Side-Effects

NCBI advances science & health by providing access to biological information

In-Utero Exposure to DES

image of PubMed logo
NCBI PubMed DiEthylStilbestrol Resources: Fetal DES-Exposure and Side-Effects.

DES Side Effects

– Bones

– Endometriosis

– Menarche

– Menopause

– Obesity

– Various Studies

More DES DiEthylStilbestrol Resources

DiEthylStilbestrol Resources: Cancer, Breast Cancer, CCAC, Vaginal Cancer, Screening

NCBI advances science & health by providing access to biological information

Cancer

image of PubMed logo
NCBI PubMed DiEthylStilbestrol Resources: Cancer, Breast Cancer, CCAC, Vaginal Cancer, Screening.

– Breast Cancer

– Clear Cell AdenoCarcinoma and Vaginal Cancer

– Screening

More DES DiEthylStilbestrol Resources

DES DiEthylStilbestrol Resources (6)

Want to know more about the pregnancy drug DiEthylStilbestrol?

DES-molecule image
Five Scary and Shocking Facts about Diethylstilbestrol
Drug companies ignored DES studies results, the FDA did NOT ban the DES drugs, it continued to be used and many new doctors don’t even know about Diethylstilbestrol.

Online Global DES Health History Survey
Calling all DES Mothers, Daughters and Sons!
Did you take part in the new 2012 Diethylstilbestrol health history survey created by DES Action USA and open to all DES-exposed individuals worldwide.

DES Daughters
What is a DES Daughter? Who are they?
Women born between 1938 and 1978, exposed to the anti miscarriage drug Diethylstilbestrol before birth (in the womb) are defined as DES Daughters.

DES Sons
What is a DES Son? Who are they?
Men born between 1938 and 1978, exposed to the anti miscarriage drug Diethylstilbestrol before birth (in the womb) are defined as DES Sons.

1000 Thanks to our 1000 Facebook Fans !
June 21th 2012 marks a Milestone in our efforts to raise awareness of the DES drug scandal and tragedy with 1000 Fans on Facebook.

More DES DiEthylStilbestrol Resources

2012 DES UK Media Coverage

Thousands of women could be at risk from silent Thalidomide

Since Sunday 22nd January 2012, there has been an unprecedented flurry of media attention on DES related health issues in the United Kingdom. This comes after two journalists – Sarah Morrison and Jaymi McCann – thoroughly investigated DES issues in the UK and published an exclusive DES report in the Independent on Sunday: “Thousands of women could be at risk from silent Thalidomide. Very quickly ripple effects started and the story spread not only throughout the country but as far as the U.S. and Australia. Many newspapers and websites caught up on the story thus increasing DES awareness locally and nationally and forcing UK health websites to update their DES information.

“Silent Thalidomide” the Secret Killer – Ten of thousands of British women in pregnancy drug scare – Exclusive Report

Independent on Sunday – Jan 22, 2012 : “Thousands of women could be at risk from silent Thalidomide”

Daily Mail – Jan 22, 2012 : ‘Silent Thalidomide’: Thousands of mothers and their daughters at risk of cancer from anti-miscarriage drugs they took decades ago

Lifestyle AOl –  Jan 22, 2012 : “Anti-miscarriage drug could cause cancer in daughters of women who took it decades ago”

Yorkshire Post – Jan 23, 2012 : “Call for compensation over pregnancy drug “

Press Association ( UKPA) – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters'”

Once the story was published by the UK Press Association it started to spread all over the country, here are a few websites where it was re-published:

London Evening Standard – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters'”

Yahoo News – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Topix, Local News Bristol – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

The Bucks Herald – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Fenland Citizen – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Crawley and Horley Observer – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Pendle Today – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Harvill Echo – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Boston Standard – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Buckingham Today – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Leigh Reporter – Jan 22, 2012: “Lawyer hunts for UK ‘DES daughters”

Halifax Courier, the Voice of Calderdale – Jan 22, 2012: “Lawyer hunts for UK ‘DES daughters”

Selby Times – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Peterborough Today – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Newmarket Journal – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Scaborough Evening News – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Hastings & St Leonards Observer – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Hemel Today – Jan 27, 2012 : “Lawyer hunts for UK ‘DES daughters”

Isle of Man Examiner – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Sussex Express – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

IC Newcastle – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Diss Express – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

News Post Leader – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Guardian – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Fleetwood Weekly News – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Suffolk Free Press – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Thame Gazette – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

Pocklington Post – Jan 22, 2012 : “Lawyer hunts for UK ‘DES daughters”

………………………. The list continues endlessly to cover 16 Google Search Pages. Enter “Lawyer hunts for UK ‘DES daughters” in your Google Search Box for the full list. Jaymi McCann’s report in the Independent on Sunday truly created ripples, waves, or should I say rather a tsunami in the UK Press.

I am thrilled that the work my husband and I have been doing over the past year or so to raise DES awareness in the UK via our Social Media networks is paying off.  As far as I know when Jaymi McCann stumbled upon my “Journal of a DES daughter” she knew little about DES but my story and the information featured in my blog was enough to spark her interest. I can’t thank her enough for the extraordinary work she and Sarah Morrison have done to pull this excellent report together. I am grateful for the opportunity they’ve given me to share my DES story to such a large audience and for the repercussions the report will have for DES daughters and hopefully also DES sons and DES grandchildren in the UK . Now the UK government and the NHS must react, launch an national awareness campaign and ensure DES victims in the UK receive appropriate care and monitoring. Let’s keep the pressure on …

This slideshow requires JavaScript.

More DES DiEthylStilbestrol Resources

2011 DES Study Media Coverage

Covering DiEthylStilbestrol worldwide drug disaster

2011 DES study media coverage imageOver the past few days, there has been an unprecedented flurry of media attention on DES related health issues. This come after a long-awaited DES study was published on October 06th in the New England Journal of Medicine  (MEJM) which carefully documents elevated risk for women exposed to diethylstilbestrol (DES in short) for a host of medical problems including cancer, infertility, ectopic pregnancies, preterm labour, …. As yet, there has been no coverage from the UK press despite a call on UK journalists to make this information available to the public.

MEDIA COVERAGE IN ENGLISH

Banned pregnancy drug impacts fetal immune system – Jerusalem Post, Oct 12, 2011

DES prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus. There has been renewed interest in light of a recent report in the New England Journal of Medicine documenting lifelong health complications facing daughters of women given DES.

Diethylstilbestrol in utero affects immune system of the fetus – News Medical, Oct 11, 2011

Reproductive tissues are not the only targets of DES. The immune system is also known to be a target for estrogens. Dr. S. Ansar Ahmed, professor of immunology at Virginia Tech, led a National Institutes of Health study in the 1990s on how exposure to DES in utero affects the immune system later in life using a mouse model.

Suit Claims Drug Leads To Breast Cancer, Victim Speaks Out – 10TV.com, Oct 10, 2011

One woman spoke out on Monday after learning a drug she was given before she was born had life threatening consequences for her as an adult.

Risky pregnancy drug raised daughters’ cancer odds – News Channel 9 ABC, Oct 10, 2011

A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new federal study finds.

Pregnancy drug used decades ago raises cancer risk in offspring: studySouth Asia Mail

A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new U.S. federal study finds.

Anti-miscarriage drug victim backs campaignTheMaitlandMecury.com.au, Oct 10, 2011

A woman given the anti-miscarriage drug diethylstilbestrol supports a call for a government-backed education campaign to highlight the dangers of exposure to the medication

Podcast 133: Over 50 years later, DES’ adverse effects continue
Oct 8, 2011 – Joe Elia – Audio interview with Dr Hoover, author of the NEJM DES Study

In a follow-up to the DES drug disaster, researchers (including one of the authors of the original reports in the early 1970s) have examined reproductive health in a large cohort of women exposed to DES in utero.  Their results were published last week in the New England Journal of Medicine, and they show that the health effects apparently continue beyond the reproductive years

Study adds to furor over pregnancy drug linked to daughter’s ailmentsThe Daily.com, Karen Keller – Oct 7, 2011

The DES breast cancer lawsuit, together with a bombshell New England Journal of Medicine article published yesterday — which suggests that infertility is twice as common and that breast cancer risk is nearly doubled in “DES daughters” — has ushered in a new awareness of the drug after decades when its lingering effects went under the radar.

Women Exposed to Synthetic Estrogen Diethylstilbestrol (DES) in the Womb Face Increased Cancer Risk, Study Finds
Science Daily – Oct 6, 2011 Hayden Donnell

A large study of the daughters of women who had been given DES, the first synthetic form of estrogen, during pregnancy has found that exposure to the drug while in the womb (in utero) is associated with many reproductive problems and an increased risk of certain cancers and pre-cancerous conditions.

Women exposed to diethylstilbestrol in the womb face increased cancer risk – EurekAlert (press release) – ‎Oct 5, 2011‎

Beginning in 1940, diethylstilbestrol, known as DES, was used clinically to prevent certain complications of pregnancy. In the 1950s, clinical studies showed DES was ineffective for this purpose. In the late 1960s, an unusual occurrence of a rare

Women Exposed To Hormone In Utero Face Lifelong Health Problems – NPR (blog) – Richard Knox – ‎Oct 5, 2011‎

Back in the 1940s, ’50s and ’60s, doctors prescribed a hormone called diethylstilbestrol, or DES, to millions of pregnant women in the unfounded belief it could prevent miscarriages. Smack in the middle of this period, the deformed thalidomide babies

Synthetic estrogen use leads to health problems
New Zealand Herald

Diethylstilbestrol was prescribed in the mistaken belief it could reduce pregnancy complications, but the daughters of the women who took it are still living with its effects

Health Risks for Women Exposed to DES in Utero
Doctors Lounge – HealthDay News – ‎Oct 5, 2011‎

Women who were exposed in utero to diethylstilbestrol have a higher lifetime risk for several adverse health outcomes, according to a study published in the Oct. 6 issue of the New England Journal of Medicine.

DES Exposure Linked to Lifetime Risk of Adverse Outcomes
Family Practice News Digital Network – Mary Ann Moon – ‎Oct 5, 2011‎

In-utero exposure to diethylstilbestrol was associated with a high lifetime risk of a broad spectrum of adverse outcomes in a follow-up study of patients now in their 40s, 50s, and 60s, according to a report in the Oct. 6 issue of the New England

Effects of DES Exposure Follow Women for Decades
MedPage Today – Charles Bankhead – ‎Oct 5, 2011‎

Explain that the teratogenic effects of diethylstilbestrol have continued to exact a heavy toll throughout the lifetime of women who were exposed to the drug in utero. Point out that DES-exposed women

Pregnancy Drug is Causing Grown Daughters to Face Risk of Cancer, Infertility – AboutLawsuits.com

The daughters of women given diethylstilbestrol (DES), a drug commonly used decades ago to prevent miscarriages and birth defects, are showing high rates of breast cancer and infertility problems, according to recent research.

DES daughters (and bummmer, I’m one) have some raised health risks – Los Angeles Times – ‎Oct 5, 2011‎

Millions of women alive today were exposed to a chemical called DES – diethylstilbestrol – in their mother’s uterus. The chemical, an early synthetic estrogen, was administered to some pregnant women before 1971 to help reduce risk of miscarriages and

Prenatal exposure to synthetic estrogen ups cancer risk in daughters – TruthDive

Washington, Sept 06 (ANI): Daughters of women who took a synthetic estrogen called diethylstilbestrol (DES) while pregnant decades ago are now facing a greater chance of being infertile and developing cancer, according to a large study by the National

Pregnancy drug found to cause fertility woes, cancers
Vancouver Sun

The study in Thursday’s New England Journal of Medicine examines the daughters of females exposed in the womb to diethylstilbestrol (DES), which was prescribed in the mistaken belief it could reduce certain complications of pregnancy.

Anti-miscarriage drug DES causes multi-generational health problems – Macleans.ca

by macleans.ca on Thursday, October 6, 2011 12:56pm – 0 Comments DES (or diethylstilbestrol), an anti-miscarriage drug widely used between 1940 and 1970, has been linked to health problems—including breast cancer, infertility, difficult pregnancies and

“DES” increases women infertility and cancers
Empowered News

DES or diethylstilbestrol have been prescribed to pregnant women for the belief that it will reduce complications during pregnancy. The National Cancer Institute researchers and scientists have been following about 6500 women including those exposed to

Health Woes Still Strike Women Exposed to Banned Pregnancy Drug – U.S. News & World Report – ‎Oct 5, 2011‎

Women whose mothers were given the drug diethylstilbestrol (DES) during pregnancy are at increased risk for fertility problems and cancer as they age, new research shows. This study from the US National Cancer

DES cancer link sparks campaign call
Sydney Morning Herald – ‎Oct 5, 2011‎

A study published by the New England Journal of Medicine on Thursday found daughters of women who took diethylstilbestrol (DES) while pregnant face a greater chance of being infertile and developing a rare vaginal cancer.

DES linked to cancer, infertility
Sydney Morning Herald – ‎Oct 5, 2011‎

A study appearing in Thursday’s New England Journal of Medicine examines women exposed in the womb to diethylstilbestrol (DES), which was prescribed in the mistaken belief it could reduce certain complications of pregnancy. Researchers at the National

In Utero DES Exposure Hurt Daughters’ Health
CalorieLab Calorie Counter News – ‎Oct 5, 2011‎

A comprehensive study looking at the drug diethylstilbestrol (DES) that was widely used by pregnant women in Europe and the United States to prevent problems in pregnancy such as miscarriage and premature birth from the 1940s until the 1960s suggests

Fake Hormone For Pregnant Women Causes Real Cancer In Their Daughters – Jezebel

The Associated Press reports that the drug, an artificial form of estrogen called DES (diethylstilbestrol), was often prescribed to pregnant women in pill or cream form between 1940 and 1960. When it was discovered that the teenage daughters of women

DES Daughters: Banned Pregnancy Drug Linked to Infertility, Prematurity and Cancer – TIME – Bonnie Rochman

That drug was DES, or diethylstilbestrol, which was widely prescribed in the US beginning in 1940 to help stave off miscarriage — until 1971, when the US Food and Drug Administration decided that the drug doesn’t work and that it causes cancer.

Risky pregnancy drug raised daughters’ cancer odds
Coshocton Tribune

Diethylstilbestrol, or DES, widely was used in the United States, Europe and elsewhere from the 1940s through the 1960s to prevent miscarriage, premature birth, bleeding and other problems. Many companies made it as pills and creams.

Moms who took miscarriage drug DES have daughters with higher risk for breast … – New York Daily News

DES, or diethylstilbestrol, was widely used in the United States, Europe and elsewhere from the 1940s through the 1960s to prevent miscarriage, premature birth, bleeding and other problems. Many companies made and sold it as pills, creams and other

Prenatal exposure to synthetic estrogen ups cancer risk in daughters – BioScholar News

Daughters of women who took a synthetic estrogen called diethylstilbestrol (DES) while pregnant decades ago are now facing a greater chance of being infertile and developing cancer, according to a large study by the National Cancer Institute in the

Pregnancy drug raised daughters’cancer odds
Post-Tribune – Marilynn Marchione – ‎Oct 5, 2011‎

Risks for other health problems vary. DES, or diethylstilbestrol, was widely used in the United States, Europe and elsewhere from the 1940s through the 1960s to prevent miscarriage, premature birth, bleeding and other problems.

Pregnancy drug raised daughters’ cancer odds
Salt Lake Tribune – Marilynn Marchione – ‎Oct 5, 2011‎

AP A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new federal study

Pregnancy Drug proving a risk for children – WREG

Millions of women in the 1940s, 50s, and 60s who wanted to make sure they had safe pregnancies, took a drug called DES. The women likely didn`t know it then, but that drug came with side effects that are surfacing 50 plus years later in their children.

Today’s Top Medical Stories for October 6, 2011
OzarksFirst.com – ‎Oct 6, 2011‎

Millions of women exposed to the first synthetic form of estrogen are at risk of cancer . A National Institutes of Health study followed daughters of pregnant women given synthetic estrogen called DES from the 1940’s to the 1970s.

Drugs women took years ago may affect daughters
WNDU-TV

A drug millions of pregnant women took decades ago may increase health risks among their daughters. An estimated four million Americans were exposed to DES, a synthetic estrogen prescribed to prevent miscarriages and pregnancy complications,

Risky pregnancy drug raised daughters’ cancer odds
KTUU – ‎Oct 5, 2011‎

A new federal study finds that a drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer. Cancer and other health problems are showing

Drug To Prevent Miscarriage Increases Odds for Breast Cancer
Heal Blog (blog) – ‎Oct 5, 2011

by Art Writ, October 6th, 2011 Decades ago, women have taken a certain drug that lessens the risk of miscarriage. However, just recently, researchers have found out that the complications and side effects of this drug has placed their daughters at

MEDIA COVERAGE IN FRENCH

L’exposition fœtale au Distilbène accroît les risques de certains cancers – Le Monde – ‎6 oct. 2011‎

Les femmes exposées dans le ventre de leur mère au Distilbène, premier œstrogène de synthèse utilisé dès 1940, souffrent de nombreux problèmes de reproduction et sont soumises à un net accroissement du risque de certains cancers, selon une vaste étude

Distilbène : de nouveaux risques de cancers identifiés
Magic Maman – ‎6 oct. 2011‎

Une étude menée par les chercheurs de l’Institut National du Cancer américain publiée aujourd’hui dans le New England Journal of Medecine révèle de nouveaux effets négatifs liés à l’exposition intra-utérine au distilbène. En cause : des risques accrus

Les femmes exposées au Distilbène au stade foetal ont plus de problèmes de santé – Maxisciences – ‎6 oct. 2011‎

Une étude menée par des chercheurs de l’Institut national américain du cancer (NCI) montre que des femmes exposées au stade fœtal au Distilbène, un œstrogène de synthèse, souffrent aujourd’hui de problèmes de reproduction et sont davantage sujettes à

Filles du Distilbène : un risque accru de cancers
Terrafemina – ‎6 oct. 2011‎

Les résultats d’une vaste étude publiée aujourd’hui dans le New England of Medicine révèlent que les femmes exposées au Distilbène dans le ventre de leur mère sont soumises à un risque accru de cancer. Entre 1948 et 1976, 200 000 femmes ont été

Reproductive tissues are not the only targets of DES. The immune system is also known to be a target for estrogens. Dr. S. Ansar Ahmed, professor of immunology at Virginia Tech, led a National Institutes of Health study in the 1990s on how exposure to DES in utero affects the immune system later in life using a mouse model.

More DES DiEthylStilbestrol Resources